PATENT CLAIM ANALYSIS

Application Number: 15753319
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "094100"]

Abstract:
Described herein are compounds and methods for tethering proteins. For example, dimers of Protein X listed in Table 1 are described, where the dimers are formed by the covalent bonding of a cysteine on the first monomer to a cysteine on the second monomer via a cyclic disulfide linker. The covalently attached dimers exhibit increased stabilization and can be used to treat neurodegenerative diseases (such as, for example, Parkinson's Disease, ALS, Alzheimer's Disease, Huntington's Disease, Epilepsy, Frontotemporal Dementia, and/or DMD), cancer, autoimmune disease, and/or Celiac disease.

Claim (Index 15):
The method of  claim 12 , wherein the compound of Formula I or the compound of Formula II forms the stabilized analogue of Formula III or Formula IV.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 88.0
- Lexical Diversity: 1.52857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14440978', '15219807', '14236041', '15827497', '11290735']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7132692165281185
- 35 USC 102 Novelty (BERT): 0.5560786615345108
- Combined Prediction Score: 0.6975501610287577
- Mean Citation Score: 302.579392
- Max Citation Score: 457.756
- Similarity Product: 249.823020910263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test